The life sciences landscape is advancing at breakneck speed, with innovations in multi-omics, large-scale biodata, and artificial intelligence redefining drug discovery and precision medicine. Yet, the R&D process remains hindered by the complexity of biological data. From single-cell RNA-seq and spatial transcriptomics to complex clinico-genomic datasets, valuable data is often trapped in unharmonized silos, rendering it unusable for modern AI applications.

At Elucidata, we help biopharma companies break free from these data bottlenecks. Our platform, Polly, provides a unified foundation for your entire multi-omics data lifecycle. We automate the ingestion, curation, and harmonization of complex multi-modal data to create a single source of truth. Whether you are optimizing target identification workflows, scaling spatial omics pipelines, or preparing data for predictive foundation models, we turn your "messy" biological data into an AI-ready asset that accelerates discovery and reduces manual effort.

Meet Elucidata's Co-founder & CTO, Swetabh Pathak, at the Festival of Genomics, Biodata & AI Boston to learn how we are helping top biopharmaceuticals scale their data infrastructure, power AI/ML models, and bring life-saving therapeutics to market faster.